Ameriprise Financial Inc. Decreases Stake in Health Catalyst, Inc. (NASDAQ:HCAT)

Ameriprise Financial Inc. reduced its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 53.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 67,607 shares of the company's stock after selling 76,531 shares during the quarter. Ameriprise Financial Inc. owned approximately 0.11% of Health Catalyst worth $478,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HCAT. Alyeska Investment Group L.P. increased its holdings in Health Catalyst by 74.4% in the fourth quarter. Alyeska Investment Group L.P. now owns 2,019,380 shares of the company's stock valued at $14,277,000 after purchasing an additional 861,150 shares during the period. First Light Asset Management LLC increased its stake in shares of Health Catalyst by 22.0% in the fourth quarter. First Light Asset Management LLC now owns 5,241,121 shares of the company's stock valued at $37,055,000 after buying an additional 944,631 shares during the period. Northern Trust Corp raised its position in shares of Health Catalyst by 8.5% during the fourth quarter. Northern Trust Corp now owns 526,607 shares of the company's stock worth $3,723,000 after acquiring an additional 41,298 shares during the last quarter. Aquatic Capital Management LLC bought a new position in shares of Health Catalyst during the fourth quarter worth about $63,000. Finally, Susquehanna Fundamental Investments LLC acquired a new position in shares of Health Catalyst in the fourth quarter worth approximately $806,000. 85.00% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HCAT has been the subject of a number of recent analyst reports. KeyCorp decreased their target price on shares of Health Catalyst from $7.00 to $5.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Citigroup decreased their price objective on shares of Health Catalyst from $7.00 to $6.50 and set a "buy" rating for the company in a research report on Friday, April 25th. Evercore ISI lowered shares of Health Catalyst from an "outperform" rating to an "inline" rating in a report on Wednesday, April 9th. Stifel Nicolaus upped their price target on shares of Health Catalyst from $5.00 to $5.50 and gave the company a "hold" rating in a research report on Thursday, May 8th. Finally, Piper Sandler lowered their price objective on Health Catalyst from $12.00 to $8.00 and set an "overweight" rating for the company in a research report on Tuesday, February 11th. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $8.00.

Health Catalyst Stock Up 6.8%

Shares of NASDAQ:HCAT traded up $0.26 during trading on Friday, reaching $4.10. 2,094,828 shares of the stock were exchanged, compared to its average volume of 602,245. Health Catalyst, Inc. has a 1-year low of $3.49 and a 1-year high of $9.24. The stock has a fifty day moving average of $3.95 and a two-hundred day moving average of $5.40. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41. The firm has a market cap of $285.36 million, a price-to-earnings ratio of -3.04 and a beta of 1.56.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.